CHAR Price To Sales Ratio vs Capex To Depreciation Analysis

YES Stock

CAD 0.30 0.01 3.45%

CHAR Technologies financial indicator trend analysis is way more than just evaluating CHAR Technologies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CHAR Technologies is a good investment. Please check the relationship between CHAR Technologies Price To Sales Ratio and its Capex To Depreciation accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in CHAR Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Price To Sales Ratio vs Capex To Depreciation

Price To Sales Ratio vs Capex To Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CHAR Technologies Price To Sales Ratio account and Capex To Depreciation. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between CHAR Technologies' Price To Sales Ratio and Capex To Depreciation is 0.53. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of CHAR Technologies, assuming nothing else is changed. The correlation between historical values of CHAR Technologies' Price To Sales Ratio and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of CHAR Technologies are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Price To Sales Ratio i.e., CHAR Technologies' Price To Sales Ratio and Capex To Depreciation go up and down completely randomly.

Correlation Coefficient

0.53

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing CHAR Technologies stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on CHAR Technologies sales, a figure that is much harder to manipulate than other CHAR Technologies multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Most indicators from CHAR Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CHAR Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in CHAR Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Enterprise Value is likely to climb to about 45.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 131 K in 2024.

CHAR Technologies fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets
Total Assets		0.22	0.57	0.86	0.95	0.27	0.36	0.14	-0.96	0.94	0.55	0.4	0.44	0.29	0.83	0.2	0.96	0.44	0.76	0.2	0.28	0.98	0.13	0.95	0.26	0.59
Short Long Term Debt Total	0.22		0.29	0.09	0.06	0.99	0.39	0.86	-0.29	0.34	-0.08	0.92	0.6	0.23	0.41	0.94	0.22	0.86	0.38	0.99	0.18	0.31	-0.1	0.25	-0.05	-0.17
Other Current Liab	0.57	0.29		0.82	0.62	0.38	0.31	0.01	-0.55	0.47	0.51	0.58	0.54	0.15	0.17	0.36	0.52	0.62	0.04	0.26	0.22	0.51	0.08	0.45	0.15	0.83
Total Current Liabilities	0.86	0.09	0.82		0.86	0.18	0.38	0.0	-0.85	0.76	0.44	0.39	0.53	0.31	0.46	0.05	0.87	0.47	0.36	0.05	0.36	0.81	0.35	0.7	0.46	0.87
Total Stockholder Equity	0.95	0.06	0.62	0.86		0.12	0.36	-0.09	-0.87	0.83	0.67	0.28	0.29	0.3	0.7	0.09	0.88	0.33	0.67	0.03	0.26	0.88	0.16	0.89	0.27	0.73
Property Plant And Equipment Net	0.27	0.99	0.38	0.18	0.12		0.42	0.86	-0.36	0.39	-0.08	0.96	0.68	0.24	0.41	0.92	0.28	0.91	0.35	0.98	0.2	0.36	-0.1	0.27	-0.04	-0.07
Current Deferred Revenue	0.36	0.39	0.31	0.38	0.36	0.42		0.37	-0.35	0.25	-0.1	0.58	0.58	0.95	0.23	0.27	0.42	0.63	0.27	0.38	0.38	0.35	0.24	0.22	0.35	0.36
Net Debt	0.14	0.86	0.01	0.0	-0.09	0.86	0.37		-0.29	0.34	-0.49	0.75	0.61	0.24	0.36	0.65	0.24	0.72	0.34	0.85	0.25	0.27	0.07	0.09	0.12	-0.34
Retained Earnings	-0.96	-0.29	-0.55	-0.85	-0.87	-0.36	-0.35	-0.29		-0.98	-0.38	-0.46	-0.5	-0.24	-0.82	-0.21	-0.98	-0.5	-0.71	-0.27	-0.19	-0.98	-0.16	-0.87	-0.28	-0.53
Accounts Payable	0.94	0.34	0.47	0.76	0.83	0.39	0.25	0.34	-0.98		0.38	0.44	0.41	0.14	0.88	0.26	0.95	0.46	0.79	0.31	0.15	0.96	0.14	0.89	0.25	0.39
Cash	0.55	-0.08	0.51	0.44	0.67	-0.08	-0.1	-0.49	-0.38	0.38		0.02	-0.14	-0.15	0.43	0.18	0.34	-0.02	0.39	-0.08	-0.08	0.46	-0.28	0.69	-0.24	0.48
Non Current Assets Total	0.4	0.92	0.58	0.39	0.28	0.96	0.58	0.75	-0.46	0.44	0.02		0.78	0.38	0.38	0.87	0.4	0.97	0.31	0.91	0.29	0.45	-0.04	0.34	0.04	0.2
Non Currrent Assets Other	0.44	0.6	0.54	0.53	0.29	0.68	0.58	0.61	-0.5	0.41	-0.14	0.78		0.48	0.25	0.48	0.5	0.86	0.15	0.63	0.57	0.51	0.08	0.28	0.19	0.36
Other Assets	0.29	0.23	0.15	0.31	0.3	0.24	0.95	0.24	-0.24	0.14	-0.15	0.38	0.48		0.14	0.09	0.37	0.46	0.24	0.21	0.46	0.27	0.4	0.15	0.5	0.32
Long Term Debt	0.83	0.41	0.17	0.46	0.7	0.41	0.23	0.36	-0.82	0.88	0.43	0.38	0.25	0.14		0.38	0.78	0.35	0.95	0.41	0.06	0.88	-0.09	0.91	0.01	0.06
Cash And Short Term Investments	0.2	0.94	0.36	0.05	0.09	0.92	0.27	0.65	-0.21	0.26	0.18	0.87	0.48	0.09	0.38		0.11	0.77	0.34	0.95	0.08	0.25	-0.32	0.3	-0.27	-0.12
Net Receivables	0.96	0.22	0.52	0.87	0.88	0.28	0.42	0.24	-0.98	0.95	0.34	0.4	0.5	0.37	0.78	0.11		0.46	0.71	0.19	0.32	0.97	0.3	0.85	0.43	0.57
Common Stock Shares Outstanding	0.44	0.86	0.62	0.47	0.33	0.91	0.63	0.72	-0.5	0.46	-0.02	0.97	0.86	0.46	0.35	0.77	0.46		0.28	0.85	0.34	0.48	0.05	0.33	0.15	0.31
Short Term Investments	0.76	0.38	0.04	0.36	0.67	0.35	0.27	0.34	-0.71	0.79	0.39	0.31	0.15	0.24	0.95	0.34	0.71	0.28		0.37	0.17	0.79	0.06	0.85	0.15	0.01
Non Current Liabilities Total	0.2	0.99	0.26	0.05	0.03	0.98	0.38	0.85	-0.27	0.31	-0.08	0.91	0.63	0.21	0.41	0.95	0.19	0.85	0.37		0.18	0.3	-0.21	0.25	-0.15	-0.2
Other Current Assets	0.28	0.18	0.22	0.36	0.26	0.2	0.38	0.25	-0.19	0.15	-0.08	0.29	0.57	0.46	0.06	0.08	0.32	0.34	0.17	0.18		0.28	0.46	0.21	0.49	0.28
Total Liab	0.98	0.31	0.51	0.81	0.88	0.36	0.35	0.27	-0.98	0.96	0.46	0.45	0.51	0.27	0.88	0.25	0.97	0.48	0.79	0.3	0.28		0.11	0.94	0.24	0.48
Short Long Term Debt	0.13	-0.1	0.08	0.35	0.16	-0.1	0.24	0.07	-0.16	0.14	-0.28	-0.04	0.08	0.4	-0.09	-0.32	0.3	0.05	0.06	-0.21	0.46	0.11		-0.02	0.99	0.31
Total Current Assets	0.95	0.25	0.45	0.7	0.89	0.27	0.22	0.09	-0.87	0.89	0.69	0.34	0.28	0.15	0.91	0.3	0.85	0.33	0.85	0.25	0.21	0.94	-0.02		0.09	0.41
Short Term Debt	0.26	-0.05	0.15	0.46	0.27	-0.04	0.35	0.12	-0.28	0.25	-0.24	0.04	0.19	0.5	0.01	-0.27	0.43	0.15	0.15	-0.15	0.49	0.24	0.99	0.09		0.39
Intangible Assets	0.59	-0.17	0.83	0.87	0.73	-0.07	0.36	-0.34	-0.53	0.39	0.48	0.2	0.36	0.32	0.06	-0.12	0.57	0.31	0.01	-0.2	0.28	0.48	0.31	0.41	0.39

Click cells to compare fundamentals

CHAR Technologies Account Relationship Matchups

CHAR Technologies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.4M	10.3M	9.9M	18.9M	465.4K	442.1K
Other Current Liab	98.7K	3.0M	2.4M	1.1M	1.2M	754.1K
Total Current Liabilities	874.8K	3.9M	4.4M	3.2M	120.4K	114.4K
Total Stockholder Equity	1.3M	5.5M	4.7M	6.9M	303.4K	288.2K
Property Plant And Equipment Net	1.2M	1.5M	3.8M	9.2M	10.5M	11.1M
Current Deferred Revenue	525.0K	506.9K	596.1K	598.3K	688.0K	550.8K
Net Debt	172.4K	(2.7M)	426.4K	1.7M	2.0M	2.1M
Retained Earnings	(5.5M)	(8.8M)	(15.7M)	(24.1M)	(441.5K)	(463.6K)
Accounts Payable	209.6K	333.5K	807.6K	1.4M	50.7K	48.2K
Cash	129.1K	3.0M	460.5K	2.1M	347.4K	330.0K
Non Current Assets Total	2.7M	6.1M	7.7M	10.6M	12.2M	12.8M
Cash And Short Term Investments	129.1K	3.0M	460.5K	6.1M	7.0M	7.4M
Net Receivables	352.4K	693.4K	1.2M	1.7M	40.3K	38.3K
Common Stock Shares Outstanding	45.1M	64.0M	77.9M	88.5M	101.7M	106.8M
Liabilities And Stockholders Equity	3.4M	10.3M	9.9M	18.9M	21.7M	22.8M
Non Current Liabilities Total	1.2M	880.3K	834.5K	8.7M	10.0M	10.5M
Other Current Assets	62.2K	283.4K	229.5K	196.2K	225.7K	224.5K
Total Liab	2.1M	4.8M	5.3M	11.9M	162.0K	153.9K
Total Current Assets	658.4K	4.2M	2.2M	8.3M	396.5K	376.6K
Accumulated Other Comprehensive Income	511.1K	2.6M	5.1M	7.0M	8.1M	8.5M
Short Term Debt	41.6K	50.7K	662.5K	126.9K	41.6K	39.5K
Intangible Assets	799.9K	672.9K	3.9M	3.3M	786.3K	40.5K
Net Tangible Assets	(282.2K)	952.9K	770.3K	260.7K	234.6K	222.9K
Property Plant Equipment	1.1M	1.5M	3.8M	23.2K	26.7K	25.4K
Other Liab	1.5M	905.2K	622.4K	610.1K	549.1K	716.7K
Inventory	114.6K	270.2K	323.6K	312.5K	359.4K	227.5K
Net Invested Capital	1.5M	5.8M	5.5M	9.4M	10.8M	11.4M
Net Working Capital	(216.5K)	350.0K	(2.2M)	5.0M	5.8M	6.1M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for CHAR Stock Analysis

When running CHAR Technologies' price analysis, check to measure CHAR Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CHAR Technologies is operating at the current time. Most of CHAR Technologies' value examination focuses on studying past and present price action to predict the probability of CHAR Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CHAR Technologies' price. Additionally, you may evaluate how the addition of CHAR Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC